>>Signaling Pathways>> Chromatin/Epigenetics>> Histone Methyltransferase>>A-196

A-196

Catalog No.GC32861

A-196은 각각 25nM 및 144nM의 IC50 값을 갖는 SUV420H1 및 SUV420H2의 강력하고 선택적인 억제제입니다. A-196은 기질 경쟁 방식으로 SUV4-20을 생화학적으로 억제합니다. A-196은 게놈 무결성에서 히스톤 메틸트랜스퍼라제의 역할을 조사하기 위한 SUV4-20의 동급 최초의 화학 프로브를 나타냅니다.

Products are for research use only. Not for human use. We do not sell to patients.

A-196 Chemical Structure

Cas No.: 1982372-88-2

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$80.00
재고 있음
1mg
US$56.00
재고 있음
5mg
US$102.00
재고 있음
10mg
US$167.00
재고 있음
50mg
US$547.00
재고 있음
100mg
US$881.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

A-196 is a potent and selective chemical inhibitor of SUV420H1 and SUV420H2 that inhibits the di- and trimethylation of H4K20me in multiple cell lines. Target: A-196 is a selective chemical probe for SUV420H1/H2. A-196 is the first potent and selective chemical probe for SUV420H1 and SUV420H2. The in vitro activity of A-196 includes inhibition of SUV420H1 with IC50 = 25 nM and SUV420H2 with IC50 = 144 nM for methylation of H4K20me and greater than 100-fold selectivity over other histone methyltransferases and non-epigenetic targets. In cell assays, A-196 inhibits the di- and tri-methylation of H4K20me in multiple cell lines with IC50 < 1 μM. SUV420H1 and SUV420H2 are two highly homologous methyltransferases that di- and tri-methylate 'Lys-20' of histone H4.

리뷰

Review for A-196

Average Rating: 5 ★★★★★ (Based on Reviews and 15 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for A-196

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.